LeadStory

Reuters

AstraZeneca to invest $50 bln in U.S. as pharma tariffs loom

Reuters · Recent
Reuters
Reuters
Recent

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy.

Breakdown
  • AstraZeneca will invest $50 billion in the US by 2030, including a new factory in Virginia.
  • The investment comes as the US considers tariffs on imported pharmaceuticals and urges more domestic production. 16s
  • AstraZeneca's CEO said global drug prices should equalize, with higher prices outside the US to support R&D. 32s
  • The US government has indicated tariffs may be imposed soon, with companies given up to 18 months to adjust. 47s
  • AstraZeneca's move follows similar investments by other major pharmaceutical firms and is expected to create tens of thousands of jobs. 1m 14s
Companies & StartupsBusiness